Literature DB >> 1580795

Somatofugal axonal atrophy precedes development of axonal degeneration in acrylamide neuropathy.

B G Gold1, J W Griffin, D L Price.   

Abstract

Somatofugal axonal atrophy is part of the neuronal perikaryal response to axonal injury (axon reaction). Chronic administration of acrylamide (AC) produces proximal atrophy in virtually all sensory fibers in lumbar dorsal root ganglion (DRG) despite the presence of many intact axons in the distal portion of the sciatic nerve. This suggests that the development of axonal atrophy in AC-intoxicated animals is not solely due to a toxic chemical-induced axonal degeneration (axotomy). In this study, we asked whether axonal atrophy arises before onset of axonal degeneration. Rats were given a single intraperitoneal (i.p.) high dose of AC (75 mg/kg), which blocks retrograde axonal transport, followed by daily intraperitoneal injections (30 mg/kg, for 4 days). At 5 days, sensory fibers in the L4 and L5 DRG appeared smaller in caliber and less circular in shape compared to fibers from age-matched normal animals. Axonal diameters of sensory fibers in the L5 dorsal root were significantly (p less than 0.05) reduced at distances up to 2 mm from the DRG. Quantitative electron microscopy demonstrated that the reduction in caliber was due to a decreased neurofilament (NF) content. Axonal degeneration was not present in the distal portion of both centrally (dorsal root) and peripherally (sciatic nerve) projecting sensory fibers at this time, although primary afferent terminals in muscles of the hindfeet were packed with NFs. The somatofugal progression of the atrophy was evident following more prolonged exposures (10-28 days). It is suggested that AC produces somatofugal axonal atrophy by inhibiting the delivery of a retrogradely transported target-derived "trophic" signal to the neuronal perikaryon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580795     DOI: 10.1007/bf02307271

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  45 in total

1.  Neurofilament antigens in acrylamide neuropathy.

Authors:  B G Gold; D L Price; J W Griffin; J Rosenfeld; P N Hoffman; N H Sternberger; L A Sternberger
Journal:  J Neuropathol Exp Neurol       Date:  1988-03       Impact factor: 3.685

2.  Axonal degeneration and axonal caliber alterations following combined beta,beta'-iminodipropionitrile (IDPN) and acrylamide administration.

Authors:  B G Gold; M M Halleck
Journal:  J Neuropathol Exp Neurol       Date:  1989-11       Impact factor: 3.685

3.  Peripheral neuropathy in rats produced by acrylamide.

Authors:  P M Fullerton; J M Barnes
Journal:  Br J Ind Med       Date:  1966-07

4.  Changes in cytoskeletal proteins in the rat facial nucleus following axotomy.

Authors:  W Tetzlaff; M A Bisby; G W Kreutzberg
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

5.  Neurofilament degradation in the nervous system of rats intoxicated with acrylamide, related compounds or 2,5-hexanedione.

Authors:  H Tanii; M Hayashi; K Hashimoto
Journal:  Arch Toxicol       Date:  1988-08       Impact factor: 5.153

6.  Neurofilament accumulation induced in synapses by leupeptin.

Authors:  B I Roots
Journal:  Science       Date:  1983-09-02       Impact factor: 47.728

7.  Rôle of axonal transport in maintaining central synaptic connections.

Authors:  R E Cull
Journal:  Exp Brain Res       Date:  1975-11-28       Impact factor: 1.972

8.  Inhibition of fast axonal transport and microtubule polymerization in vitro by colchicine and colchiceine.

Authors:  A Edström; M Hanson; M Wallin; B Cederholm
Journal:  Acta Physiol Scand       Date:  1979-11

9.  'Acrylamide-induced' neuropathy and impairment of axonal transport of proteins. II. Abnormal accumulations of smooth endoplasmic reticulum as sites of focal retention of fast transported proteins. Electron microscope radioautographic study.

Authors:  M Chretien; G Patey; F Souyri; B Droz
Journal:  Brain Res       Date:  1981-01-26       Impact factor: 3.252

10.  Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration.

Authors:  B G Gold; J W Griffin; D L Price
Journal:  J Neurosci       Date:  1985-07       Impact factor: 6.167

View more
  7 in total

1.  Acrylamide alters cytoskeletal protein level in rat sciatic nerves.

Authors:  Sufang Yu; Fuyong Son; Jinxia Yu; Xiulan Zhao; Lihua Yu; Guozhen Li; Keqin Xie
Journal:  Neurochem Res       Date:  2006-10-17       Impact factor: 3.996

2.  The volume of Purkinje cells decreases in the cerebellum of acrylamide-intoxicated rats, but no cells are lost.

Authors:  J Overgaard Larsen; T Tandrup; H Braendgaard
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

3.  Unexpected survival of neurons of origin of the pyramidal tract after spinal cord injury.

Authors:  Jessica L Nielson; Ilse Sears-Kraxberger; Melissa K Strong; Jamie K Wong; Rafer Willenberg; Oswald Steward
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

4.  The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves.

Authors:  Bogdan Beirowski; Robert Adalbert; Diana Wagner; Daniela S Grumme; Klaus Addicks; Richard R Ribchester; Michael P Coleman
Journal:  BMC Neurosci       Date:  2005-02-01       Impact factor: 3.288

5.  Acrylamide neurotoxicity on the cerebrum of weaning rats.

Authors:  Su-Min Tian; Yu-Xin Ma; Jing Shi; Ting-Ye Lou; Shuai-Shuai Liu; Guo-Ying Li
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

6.  Effect of partial hysterectomy on the neurons of the paracervical ganglion (PCG) of the pig.

Authors:  Piotr Podlasz; Krzysztof Wasowicz
Journal:  PLoS One       Date:  2021-01-26       Impact factor: 3.240

7.  A glycolytic shift in Schwann cells supports injured axons.

Authors:  Elisabetta Babetto; Keit Men Wong; Bogdan Beirowski
Journal:  Nat Neurosci       Date:  2020-08-17       Impact factor: 24.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.